Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Needham Reiterates Buy on Genpact, Maintains $56 Price Target

Needham analyst Mayank Tandon reiterates Genpact (NYSE:G) with a Buy and maintains $56 price target.

byBenzinga Newsdesk

February 10, 2023

1 minute read

Needham analyst Mayank Tandon reiterates Genpact (NYSE:G) with a Buy and maintains $56 price target.

Raymond James Downgrades Horizon Bancorp to Outperform, Lowers Price Target to $22

By Benzinga Newsdesk

Today, 11:03 PM

Raymond James analyst David Long downgrades Horizon Bancorp (NASDAQ:HBNC) from Strong Buy to Outperform and lowers the price target from $23 to $22.

HBNC

Herc Holdings Q2 EPS $2.47 Misses $2.64 Estimate, Sales $640.40M Beat $630.14M Estimate

By Benzinga Newsdesk

Today, 11:03 PM

Herc Holdings (NYSE:HRI) reported quarterly earnings of $2.47 per share which missed the analyst consensus estimate of $2.64 by 6.44 percent. This is a 57.32 percent increase over earnings of $1.57 per share from the

HRI

Macquarie Upgrades UiPath to Outperform, Lowers Price Target to $47

By Benzinga Newsdesk

Today, 11:03 PM

Macquarie analyst Frederick Havemeyer upgrades UiPath (NYSE:PATH) from Neutral to Outperform and lowers the price target from $55 to $47.

PATH

News
Tech

Twitter is Reviewing its Policies Regarding Permanent User Bans

By Charles Gross

Today, 11:03 PM

-FT https://www.ft.com/content/15cb54bd-86b0-49d8-8258-cee79b2faa4c

TWTR

Needham Reiterates Buy on Genpact, Maintains $56 Price Target

Related Posts

Raymond James Downgrades Horizon Bancorp to Outperform, Lowers Price Target to $22

Herc Holdings Q2 EPS $2.47 Misses $2.64 Estimate, Sales $640.40M Beat $630.14M Estimate

Macquarie Upgrades UiPath to Outperform, Lowers Price Target to $47

Twitter is Reviewing its Policies Regarding Permanent User Bans